We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Airway Microbiome Altered in Severe Asthma Linked to Neutrophils

By LabMedica International staff writers
Posted on 06 Jun 2019
Patients with mild-to-moderate asthma can experience difficulty breathing and it is especially difficult for those with Severe Asthma where symptoms can be life threatening. More...
In either case, patients cannot participate in daily activities if their disease is uncontrolled.

As there is no single ‘gold standard’ test, clinical asthma diagnosis is based on evidence of recurrent respiratory symptoms; reversibility with anti-asthma treatment; and variable airflow obstruction. Demonstrating any or all three, of these features in a clinical setting is challenging as the disease fluctuates.

A team of scientists working with the Global Medical Franchise GSK (Brentford, UK) utilized sputum metagenomic profiling to determine if there was a relationship between neutrophilic inflammation and the airway microbiome in severe asthma. No previous metagenomic analysis has been undertaken in severe asthma to understand this relationship. Induced sputum was obtained from four cohorts as part of the U-BIOPRED study programme: (A) 97 severe asthma, non-smokers, (B) 50 severe asthma, ex/current smokers, (C) 25 steroid treated non-severe asthma and (D) 23 healthy controls.

Samples were prepared for sequencing with the Illumina Nextera kit and quantified with Quant-iT dsDNA High Sensitivity assays. Libraries were pooled and run with 100 bp paired-end sequencing protocols on the Illumina HiSeq 2500 platform., Taxonomic profiling (MetaPhlAn2), reads mapped to KEGG v75.0 (Diamond), accepting hits ≥20 amino acids with ≥80% similarity and pathway counts derived from summing the relative abundance of KOs to the pathway(s) they belong to.

The scientists reported that there were reductions in the richness and diversity between severe asthmatics and the two control cohorts. On analysis of the metagenomic profiles, taxa alpha diversity inversely correlated with sputum neutrophil percent. Veillonellaceae, Prevotellaceae, Neisseriaceae, Streptococcaceae, Porphyromonadaceae, and Micrococcaceae were all negatively correlated with percent neutrophils. Moraxellaceae was positively correlated with percent neutrophils. The team reported 67 Operational Taxonomic units (OTUs) were significantly correlated with percent neutrophils, and 65 OTUs were negatively correlated with percent neutrophils. Two OTUs: Moraxella catarrhalis and Haemophilus influenzae, were positively correlated. Thirty genes were negatively correlated with percent neutrophils. There was no correlation with sputum eosinophils.

The authors that their study associates an abnormal airway metagenomic profile in severe asthma with neutrophilic airway inflammation. Further focus is needed to better understand the dynamics of this relationship, as severe neutrophilic asthma remains an important clinically unmet need. The study was presented on May 22, 2019, at the American Thoracic Society Annual Meeting, held May 17-22, 2019, in Dallas, Texas, USA.

Related Links:
Global Medical Franchise GSK


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Researcher Joris Deelen (Photo courtesy of Elton Alisson/Agência FAPESP)

Blood-Based Score May Support Targeted Interventions for Healthier Aging

Chronic diseases frequently accumulate with age, complicating efforts to maintain functional independence in older adults. Studies cited by the investigators indicate that about 60% of people over age... Read more

Molecular Diagnostics

view channel
Image Credit: Shutterstock

Blood Test Identifies Early Breast and Prostate Cancer Signals Years Before Diagnosis

Breast and prostate cancers are among the most common cancers, yet many are detected only after tumors have become established. Identifying disease earlier could support closer monitoring and help distinguish... Read more

Hematology

view channel
Image: Mayo Clinic researchers used genetic data from nearly 50,000 participants to identify sickle cell and beta-thalassemia carrier traits, highlighting how population-scale testing can complement existing screening (Image Credit: Adobe Stock)

Genetic Testing Offers Opportunities for Earlier Blood Disorder Carrier Identification

Inherited hemoglobin disorders can affect oxygen transport, yet individuals who carry only a trait may remain unaware of their status. People with sickle cell trait or beta-thalassemia trait often have... Read more

Pathology

view channel
Image Credit: Adobe Stock

AI Pathology Approach Closely Aligns With Breast Cancer Genomic Risk Classification

In early-stage breast cancer, precision oncology relies on biological information to guide personalized treatment decisions. Because access to tissue-based genomic testing may be limited, there is growing... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.